483
Nanova Biomaterials IncFDA 483 - Nanova Biomaterials Inc - February 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Nanova Biomaterials Inc in Columbia, MO, from February 11-14, 2025, identified a significant deficiency in equipment calibration procedures. The firm was found to have used expired fluoride standards to verify the 5% fluoride content of its Sodium Fluoride Varnish, affecting products manufactured and sold since November 2022. This indicates a lapse in quality control and compliance with manufacturing standards.
- Person
Open in Dashboard
ID · 455b2b41-8812-4ee9-b5b3-da85bc57cba0